Manufacturing News of Note—Thermo Fisher closes on GSK plant; Vetter invests $100M; Lupin names ex-Apotex exec head of quality 

stocks
(Pixabay)

> Waltham, Massachusetts-based Thermo Fisher Scientific has completed its €90 million buyout of a GlaxoSmithKline API site in Cork, Ireland. Release 

> German CDMO Vetter says it will invest $100 million to upgrade its production lines at sites in Germany and the U.S. to increase filling capacity. Story

> Lupin, which has been struggling with manufacturing quality, has named as its new global head of quality Johnny Mikell. He comes from Apotex, another drugmaker with a history of FDA manufacturing issues. Release 

> Lupin has received a Form 483 with three observations for its Tarapur plant. Story 

> South Plainfield, New Jersey-based biotech PTC Therapeutics has struck a deal with Aldevron to manufacture its gene therapy portfolio. Release 

> Boehringer Ingelheim has completed a $76 million expansion at its plant at Athens, Georgia, which doubles its pet vaccine capacity. Release

> Merck KGaA’s MilliporeSigma has acquired for an undisclosed amount Wilbraham, Massachusetts-based FloDesign Sonics, which has developed an acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Release

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.